Highlights•Various challenges in the vaccination process of Dutch immunocompromised patients.•Affordability and knowledge deficit were the most important challenges.•Stakeholders want a fair reimbursement for their efforts to improve the process.•Stakeholders need to cooperate more to solve the reimbursement and guidelines issue.•Rarely the same solutions to challenges in ICP vaccination process were mentioned.